<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04110704</url>
  </required_header>
  <id_info>
    <org_study_id>261294</org_study_id>
    <secondary_id>42833</secondary_id>
    <nct_id>NCT04110704</nct_id>
  </id_info>
  <brief_title>Cerclage After Full Dilatation Caesarean Section</brief_title>
  <acronym>CRAFT</acronym>
  <official_title>An Investigation Into the Role of Previous in Labour Caesarean Section in Future Preterm Birth Risk and Management Strategies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in
      women with a history of previous caesarean in established labour. This prospective study
      using clinically acquired cervical length and quantitative fetal fibronectin data will help
      establish a predictive model of preterm birth &lt;34 weeks and &lt;37 weeks.

      CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at
      high risk of preterm birth following a caesarean section at full dilatation

      CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features
      within the cervix which predisposes to preterm birth in women with a previous full dilatation
      caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to
      assess if structural changes can be visualised in the cervix.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CRAFT-OBS: Number of participants with spontaneous preterm birth rate &lt; 37 weeks gestation</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>CRAFT-RCT: Number of participants with spontaneous preterm birth &lt;34 weeks gestation</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity.</measure>
    <time_frame>Up to 48 weeks</time_frame>
    <description>We will assess the number of antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services)</measure>
    <time_frame>Up to 48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Number of participants who deliver &lt;34 weeks gestation</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Gestation at delivery</measure>
    <time_frame>Up to 42 weeks</time_frame>
    <description>The proportion of participants who delivery at each gestation of completed weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Any cervical length measurements taken antenatally</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Number of antenatal hospital appointments</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Number of hospital admissions</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: cervicovaginal fetal fibronectin protein levels taken at any gestation if taken</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Number of ultrasound indicated antenatal interventions</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Predictive modelling (QUIPP app) to evaluate the ability of CL and fFN to determine risk of preterm birth &lt;34 and &lt;37 weeks</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-OBS: Number of participants with other maternal and fetal morbidities, as per COPOP core outcome set for preterm birth intervention studies</measure>
    <time_frame>Up to 48 weeks</time_frame>
    <description>COPOP core outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-RCT: Number of participants with an adverse perinatal outcome</measure>
    <time_frame>Up to 48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-RCT: Gestation at delivery</measure>
    <time_frame>Up to 42 weeks</time_frame>
    <description>Proportion of participants who deliver at each gestation of completed weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-RCT: Number of women needing insertion of a rescue cerclage (done when membranes exposed or bulging)</measure>
    <time_frame>Up to 30 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-RCT: Time between intervention and delivery.</measure>
    <time_frame>Up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-RCT - Health costs at 28 days post-delivery.</measure>
    <time_frame>Up to 48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRAFT-IMG: Evidence of cervical injury</measure>
    <time_frame>Up to 40 weeks</time_frame>
    <description>Size of any cervical lesion and its location seen on MRI or ultrasound scans</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Preterm Birth</condition>
  <condition>Preterm Premature Rupture of Membrane</condition>
  <condition>Preterm Spontaneous Labor With Preterm Delivery</condition>
  <arm_group>
    <arm_group_label>Transvaginal cerclage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Active monitoring</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insertion of transvaginal cerclage</intervention_name>
    <description>Transvaginal cerclage is inserted in women with a high risk of preterm birth. However it is unknown whether this alongside cervical length monitoring improves the incidence of preterm birth. The cerclage is inserted under regional analgesia.</description>
    <arm_group_label>Transvaginal cerclage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        CRAFT-OBS

        Inclusion Criteria:

          -  Pregnant women under 23+6 weeks gestation with a history of previous caesarean section
             in labour.

          -  Singleton pregnancy.

          -  Willing and able to give informed consent (with or without interpreter).

        Exclusion Criteria:

          -  Under 16 years of age.

          -  Inability to give informed consent.

          -  Previous caesarean section carried out before labour.

          -  Women who have been commenced on management with progesterone, a cerclage or arabin
             pessary as part of their care or another research study

        CRAFT-RCT:

        Inclusion criteria:

          -  Pregnant women up to 23+6 weeks gestation with a history of FDCS.

          -  Short cervix (&lt;=25mm) on transvaginal ultrasound scan.

        Exclusion criteria:

          -  Women with persistent fresh vaginal bleeding evident on speculum examination.

          -  Women with visible fetal membranes evident on speculum examination or open cervix on
             ultrasound scan.

          -  Women with severe abdominal pain/evidence of sepsis (as judged by attending
             clinician).

          -  Known significant congenital or structural or chromosomal fetal abnormality.

          -  Suspected or proven rupture of the fetal membranes at the time of recruitment.

        CRAFT-IMG

        Inclusion criteria:

          -  Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS.

        Exclusion criteria:

          -  Contraindications to MRI, e.g. claustrophobia, BMI &gt;40 kg/m2 (due to technical
             limitations of scanner) or a women with a non-MRI compatible metallic implant.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Agnieszka Glazewska-Hallin</last_name>
    <phone>020 7188</phone>
    <phone_ext>8151</phone_ext>
    <email>agnieszka.glazewska-hallin@kcl.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Waring</last_name>
    <phone>michael.waring@kcl.ac.uk</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guy's and St Thomas' Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnieszka Glazewska-Hallin</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>IRAS 261294</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://preview-kcl.cloud.contensis.com/Preview/1/research/project?id=478a6e61-4446-4a12-945e-c41a3879371d</doc_url>
    </study_doc>
  </study_docs>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/04/NCT04110704/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

